Oct 29, 2025 09:01AM
Oct 27, 2025 06:53AM
Oct 22, 2025 12:36PM
Oct 17, 2025 12:49PM
Oct 17, 2025 05:09AM
Oct 16, 2025 04:06PM
Oct 3, 2025 06:03AM Leerink Partners Starts I-Mab (IMAB) at Outperform
Sep 9, 2025 06:01AM
Sep 8, 2025 08:30AM
Aug 28, 2025 01:15PM
Aug 21, 2025 06:36AM
Aug 20, 2025 05:02PM
Aug 1, 2025 08:01AM
Jul 17, 2025 07:02AM I-Mab acquires Bridge Health to strengthen givastomig IP rights
Jul 2, 2025 11:15AM
Jun 30, 2025 04:01PM
Jun 27, 2025 06:52AM
Jun 26, 2025 06:31AM
Jun 24, 2025 06:52AM
Jun 12, 2025 07:01AM
May 28, 2025 07:34AM Lucid Capital Markets Starts I-Mab (IMAB) at Buy
Apr 4, 2025 06:41AM
Mar 21, 2025 04:31PM
Mar 7, 2025 07:00AM
Jan 8, 2025 07:03AM
Nov 14, 2024 07:06AM
Nov 6, 2024 07:01AM
Sep 16, 2024 04:01PM I-Mab Biopharma (IMAB) Presents Updated Phase 1 Givastomig Data at ESMO 2024
Sep 16, 2024 07:29AM
Sep 10, 2024 07:05AM
Aug 28, 2024 07:08AM
Jul 15, 2024 07:31AM

408,687 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All